Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001484883 | SCV001689307 | likely benign | Bloom syndrome | 2024-09-12 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002449283 | SCV002732152 | uncertain significance | Hereditary cancer-predisposing syndrome | 2024-05-04 | criteria provided, single submitter | clinical testing | The p.P76L variant (also known as c.227C>T), located in coding exon 2 of the BLM gene, results from a C to T substitution at nucleotide position 227. The proline at codon 76 is replaced by leucine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |